Fresenius Medical Care North America Unveils National Intensive Renal Care Reserve in Response to COVID-19
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
We are actively monitoring the novel coronavirus (COVID-19) pandemic. Learn About the steps that we are taking to protect our patients, employees, physicians, and partners. If you are a patient with questions or concerns, please find additional information at FreseniusKidneyCare.com and AzuraVascularCare.com
With comprehensive solutions for people living with chronic kidney disease and related conditions, we are working together to improve the quality of life of every patient, every day. We are transforming healthcare through research, innovation, and compassion.
This year's Global Annual Medical Report explores the power of ideas and the role Fresenius Medical Care can play in tranforming care for people with chronic illness across the globe. While offering detail on a range of research studies, pilot programs, and specific initiatives, this report shares our collective progress and learnings to spark ongoing dialgue and greater collaboration.
Bill Valle, CEO Fresenius Medical Care North America